Exel Composites has signed a frame agreement with Tratos for the supply of composite conductor cores for the period 2026-2029. The agreement includes a minimum volume commitment of at least €22 ...

Riyadh, Saudi Arabia - Exel by Merak, a subsidiary of Merak Capital and Saudi Arabia’s premier innovation platform company, has concluded the Demo Day for its second gaming accelerator cohort, marking ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Exelixis is still reasonably priced after its run, this ...

Exelixis is looking to break out beyond its cabozantinib franchise. The company reported big earnings growth in 2025. Zanzalintinib could be Exelixis' next big cancer therapy. The company has a ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, ...